The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Durvalumab (D) in combination with olaparib (O) for advanced, previously treated non-small cell lung cancer (NSCLC).
 
Daniel Desmond
No Relationships to Disclose
 
Rasa Vilimas
No Relationships to Disclose
 
Cristina Mullenix
No Relationships to Disclose
 
Chen Zhao
No Relationships to Disclose
 
Eva Szabo
No Relationships to Disclose
 
Meenakshi Shelat
No Relationships to Disclose
 
Madison Ballman
No Relationships to Disclose
 
Susan Sansone
No Relationships to Disclose
 
Seth M. Steinberg
No Relationships to Disclose
 
Jung-Min Lee
Research Funding - AstraZeneca (Inst); Lilly (Inst)
 
Arun Rajan
Research Funding - Bayer (Inst); EMD Serono/Merck (Inst); Phosplatin Therapeutics (Inst)